699 filings
Page 12 of 35
424B5
TLPH
Talphera Inc.
21 Jan 21
Prospectus supplement for primary offering
5:29pm
424B5
TLPH
Talphera Inc.
19 Jan 21
Prospectus supplement for primary offering
4:31pm
8-K
TLPH
Talphera Inc.
14 Jan 21
AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements
8:53am
424B5
TLPH
Talphera Inc.
10 Dec 20
Prospectus supplement for primary offering
4:17pm
8-K
TLPH
Talphera Inc.
10 Dec 20
Securities Purchase Agreement
4:16pm
10-Q
2020 Q3
TLPH
Talphera Inc.
Quarterly report
5 Nov 20
4:32pm
8-K
TLPH
Talphera Inc.
5 Nov 20
AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results
4:16pm
SC 13G
TLPH
Talphera Inc.
27 Oct 20
ACELRX PHARMACEUTICALS / BML Investment Partners ownership change
4:04pm
SC 13G
TLPH
Talphera Inc.
27 Oct 20
ACELRX PHARMACEUTICALS / BML Investment Partners ownership change
3:50pm
8-K
TLPH
Talphera Inc.
6 Oct 20
Entry into a Material Definitive Agreement
4:07pm
10-Q
2020 Q2
TLPH
Talphera Inc.
Quarterly report
10 Aug 20
4:20pm
8-K
TLPH
Talphera Inc.
10 Aug 20
AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results
4:01pm
424B5
TLPH
Talphera Inc.
23 Jul 20
Prospectus supplement for primary offering
4:39pm
8-K
TLPH
Talphera Inc.
23 Jul 20
AcelRx expands DSUVIA commercial opportunity with an established, leading partner to advance surgical care
8:50am
EFFECT
TLPH
Talphera Inc.
9 Jul 20
Notice of effectiveness
12:15am
CORRESP
TLPH
Talphera Inc.
7 Jul 20
Correspondence with SEC
12:00am
CORRESP
TLPH
Talphera Inc.
6 Jul 20
Correspondence with SEC
12:00am
CORRESP
TLPH
Talphera Inc.
6 Jul 20
Correspondence with SEC
12:00am
EFFECT
TLPH
Talphera Inc.
18 Jun 20
Notice of effectiveness
12:15am
UPLOAD
TLPH
Talphera Inc.
17 Jun 20
Letter from SEC
12:00am